Severe allergic reaction (e.g., anaphylaxis) after a previous dose of any meningococcal-, H. influenzae type b-, or tetanus toxoid-containing vaccine or any component of this vaccine is a contraindication to administration of MENHIBRIX [see DESCRIPTION].
Last reviewed on RxList: 7/23/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional MenHibrix Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.